LifeMD, Inc. Common Stock (LFMD) is a publicly traded Healthcare sector company. As of September 22, 2026, LFMD trades at $3.30 with a market cap of $155.45M and a P/E ratio of 13.18. LFMD moved +2.64% today. Year to date, LFMD is -3.23%; over the trailing twelve months it is -49.62%. Its 52-week range spans $2.56 to $15.84. Analyst consensus is strong buy with an average price target of $8.29. Rallies surfaces LFMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for LFMD, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $3.30 |
| Market Cap | $155.45M |
| P/E Ratio | 13.18 |
| EPS | $0.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.84 |
| 52-Week Low | $2.56 |
| Volume | 461.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $194.06M |
| Net Income | $15.62M |
| Gross Margin | 85.72% |
7 analysts cover LFMD: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.29.